NKGen Biotech, Inc. (OTC LINK:NKGN) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on January 20, 2026.
The Healthcare company reported Q0 revenue of $0.
NKGen Biotech, Inc.'s stock currently trades at $0.06 with a market capitalization of $4,601,939.